Holen Sie sich die Stockscreener-App
27.76
0.22%
-0.06
Schlusskurs vom Vortag:
$27.82
Offen:
$28.09
24-Stunden-Volumen:
678.55K
Relative Volume:
0.49
Marktkapitalisierung:
$1.89B
Einnahmen:
$2.74B
Nettoeinkommen (Verlust:
$-441.40M
KGV:
-4.2446
EPS:
-6.54
Netto-Cashflow:
$13.00M
1W Leistung:
+1.50%
1M Leistung:
+1.42%
6M Leistung:
-7.16%
1J Leistung:
-26.17%
1-Tages-Spanne:
$27.51
$28.30
1-Wochen-Bereich:
$26.25
$28.30
52-Wochen-Spanne:
$19.50
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Firmenname
Quidelortho Corporation
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Vergleichen Sie QDEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
27.76 | 1.89B | 2.74B | -441.40M | 13.00M | -6.54 |
|
ABT
Abbott Laboratories
|
125.08 | 218.05B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.52 | 144.86B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.02 | 139.34B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.36 | 130.75B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.19 | 49.78B | 5.88B | 1.34B | 799.60M | 2.3489 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corporation Aktie (QDEL) Neueste Nachrichten
What is the fair value estimate for QuidelOrtho Corporation (QL1A) stock in 2025July 2025 Institutional & Scalable Portfolio Growth Methods - Newser
Rhumbline Advisers Increases Stake in QuidelOrtho Corporation $QDEL - MarketBeat
Is QuidelOrtho Corporation (QL1A) stock a top dividend aristocrat candidateQuarterly Trade Report & Real-Time Volume Analysis Alerts - Newser
Is QuidelOrtho Corporation (QL1A) stock testing key support2025 Key Lessons & Growth Focused Entry Reports - Newser
QuidelOrtho (QDEL): Revisiting the Valuation After Insider Buying and a Recent Shift in Investor Sentiment - simplywall.st
Can QuidelOrtho Corporation stock beat analyst upgradesPortfolio Profit Report & Stock Market Timing Techniques - Newser
Systematic Financial Management LP Has $6.49 Million Stake in QuidelOrtho Corporation $QDEL - MarketBeat
JPMorgan Chase & Co. Decreases Stock Position in QuidelOrtho Corporation $QDEL - MarketBeat
Is QuidelOrtho Corporation (QL1A) stock undervalued at current priceJuly 2025 Breakouts & Smart Money Movement Tracker - Newser
QuidelOrtho (QDEL) Stock Rises on Insider Buying: December 2025 UpdateNews and Statistics - IndexBox
Why QuidelOrtho (QDEL) Stock Is Up Today - Yahoo Finance
Insider Buying: QuidelOrtho (NASDAQ:QDEL) Director Purchases 370 Shares of Stock - MarketBeat
Will QuidelOrtho Corporation (QL1A) stock top growth indexesForecast Cut & Long-Term Growth Plans - Newser
Director Makes Strategic Move with QuidelOrtho Stock Purchase - TipRanks
What analysts say about QuidelOrtho Corporation stockCurrency Fluctuation Impact & Consistent Triple Returns - earlytimes.in
Is QuidelOrtho Corporation QL1A a good long term investmentTrend Following Strategies & Free Daily Investment Newsletter Subscription - earlytimes.in
Tejara Capital Ltd Reduces Stock Position in QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho Reports Strong Q3 2025 Financial Results - MSN
16,884 Shares in QuidelOrtho Corporation $QDEL Purchased by SG Americas Securities LLC - MarketBeat
American Century Companies Inc. Buys 327,003 Shares of QuidelOrtho Corporation $QDEL - MarketBeat
Is QuidelOrtho’s (QDEL) CEO Share Purchase a Sign of Renewed Management Conviction? - Yahoo Finance
Will QuidelOrtho Corporation stock outperform Nasdaq index2025 Breakouts & Breakdowns & Risk Adjusted Buy/Sell Alerts - BỘ NỘI VỤ
Will QuidelOrtho Corporation (QL1A) stock benefit from sector leadershipJuly 2025 Recap & Daily Profit Focused Screening - BỘ NỘI VỤ
QuidelOrtho Corporation (QDEL) Stock Forecasts - Yahoo! Finance Canada
Joseph Busky Acquires 4,770 Shares of QuidelOrtho (NASDAQ:QDEL) Stock - MarketBeat
QuidelOrtho: Can Core Diagnostics Carry The Story Into In 2026? - RTTNews
QuidelOrtho To Participate In Upcoming Investor Conferences - Eastern Progress
Insider Moves: QuidelOrtho’s CFO Buys Big While Director Sells - TipRanks
Dir Widder Sells 4,026 ($112K) Of QuidelOrtho Corp [QDEL] - TradingView
Dir Widder Files To Sell 4,026 Of QuidelOrtho Corp [QDEL] - TradingView
QuidelOrtho (QDEL) Stock Trades Up, Here Is Why - Finviz
QuidelOrtho CFO Busky buys $124,305 in company stock By Investing.com - Investing.com Canada
QuidelOrtho CFO Busky buys $124,305 in company stock - Investing.com
QuidelOrtho Stock Up on CEO Blaser's Share Buy | QDEL News 2025News and Statistics - IndexBox
Director Makes Bold Move with QuidelOrtho Stock Purchase! - TipRanks
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know - MSN
QuidelOrtho (Nasdaq: QDEL) plans Evercore ISI, Citi Global Healthcare fireside chats - Stock Titan
Private Management Group Inc. Raises Position in QuidelOrtho Corporation $QDEL - MarketBeat
Is QuidelOrtho Poised for a Rebound After 14% Rally and Valuation Signals? - Yahoo Finance
QuidelOrtho (QDEL) Shares Skyrocket, What You Need To Know - Finviz
Is QuidelOrtho Corporation (QL1A) stock a defensive play amid uncertaintyWeekly Trend Summary & Safe Entry Point Alerts - newser.com
Can QuidelOrtho Corporation stock sustain revenue growthMarket Activity Report & Daily Profit Focused Screening - newser.com
Brian Blaser Purchases 23,500 Shares of QuidelOrtho (NASDAQ:QDEL) Stock - MarketBeat
QuidelOrtho CEO Blaser buys $501k in company stock By Investing.com - Investing.com Nigeria
CEO Makes Bold Move with Major Stock Purchase in QuidelOrtho! - TipRanks
QuidelOrtho CEO Blaser buys $501k in company stock - Investing.com
Officer Hodges Acquires 2,632 Of QuidelOrtho Corp [QDEL] - TradingView
CEO Blaser Buys 23,500 ($501.6K) Of QuidelOrtho Corp [QDEL] - TradingView
[Form 4] QuidelOrtho Corp Insider Trading Activity - Stock Titan
The Power of Prevention: Detecting Diabetes Before It Strikes - PR Newswire
Lacklustre Performance Is Driving QuidelOrtho Corporation's (NASDAQ:QDEL) 28% Price Drop - simplywall.st
Finanzdaten der Quidelortho Corporation-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.78%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):